Name: Climb Bio, Inc. (CLYM) Financial Statements
Creator: FinSpry

Climb Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Climb Bio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.05	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.05	0.00	0.00	0.00
Operating Expenses
Research & Development	11.61	11.58	26.21	23.32	9.34
Selling, General & Administrative	15.39	9.89	18.92	12.35	2.43
Operating Expenses	27.00	21.47	45.14	35.67	11.77
Operating Income	-27.00	-21.47	-45.14	-35.67	-11.77
Other Income/Expense
Interest Income	7.38	2.29	1.38	0.45	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	8.12	-0.36	-1.48	-11.72	0.00
Income
Income Before Tax	-73.90	-35.12	-45.24	-47.48	-20.67
Income Tax Expense	0.00	0.00	0.00	-1.85	0.00
Net Income	-73.90	-35.12	-45.24	-47.48	-20.67
Net Income - Continuous Operations	-73.90	-35.12	-45.24	-47.48	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-30.36	-35.12	-45.24	-35.67	0.00
EBIT	-27.00	-21.47	-45.24	-35.67	-11.77
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-2.00	-1.00	-2.00	-4.00	-10.00
Diluted EPS	-2.00	-1.00	-2.00	-4.00	-10.00
Basic Shares Outstanding	48.16	26.99	26.31	12.26	2.19
Diluted Shares Outstanding	48.16	26.99	26.31	12.26	2.19